1.07
-0.01 (-0.93%)
-0.01 (-0.93%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Citius Pharmaceuticals Inc | CTXR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.01 | -0.93% | 1.07 | 00:00:03 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 1.07 | 1.04 | 1.09 | 1.05 | 1.08 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.03 | 1.10 | 0.07 | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 878 | 581,280 | $ 1.06 | $ 616,111 | 4,995,886 | 0.40 - 1.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:41:30 | formt | 1,000 | $ 1.07 | USD |
Citius Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 48.35M | 45.19M | 32.90M | $ - | $ - | -0.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 27.20% |
Citius Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTXR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.11 | 1.20 | 1.00 | 1.10 | 1,722,742 | -0.04 | -3.6% |
| 1 Month | 1.36 | 1.77 | 1.00 | 1.29 | 2,149,104 | -0.29 | -21.32% |
| 3 Months | 1.03 | 1.97 | 0.801 | 1.25 | 3,435,575 | 0.04 | 3.88% |
| 6 Months | 0.99 | 1.97 | 0.415 | 1.13 | 2,125,196 | 0.08 | 8.08% |
| 1 Year | 1.08 | 1.97 | 0.40 | 1.10 | 1,234,175 | -0.01 | -0.93% |
| 3 Years | 2.91 | 5.49 | 0.40 | 1.23 | 493,521 | -1.84 | -63.23% |
| 5 Years | 3.40 | 5.49 | 0.40 | 1.23 | 489,752 | -2.33 | -68.53% |
Citius Pharmaceuticals Description
| Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments. |
